SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TAKE Solutions secures patent from USPTO

24 Jun 2015 Evaluate

TAKE Solutions, a global business technology solutions provider, has been awarded a patent by the United States Patent and Trademark Office (USPTO) for its ‘Method for Optimizing Clinical Data Standardization’. This process leverages the company’s Clinical Accelerators to reduce the time taken to standardize trial data by over 50% (when compared to standardization without the accelerators), thus reducing time to market.

At the heart of the patented Clinical Data Standardization Process are the company’s Clinical Accelerators, a set of macros that accelerate the Clinical Data Standardization process where raw data from clinical trials is standardized and transformed into CDISC SDTM format. The process includes various pre-defined steps that convert raw data into tabular datasets. This enables regulators to easily understand the data, as well as enables easy analysis of trial data.

This process is delivered by Navitas, the Life Sciences arm of TAKE Solutions. The Clinical Data Services team offers its clients the benefit of company's deep domain expertise in Clinical Data solutions including - Clinical Data Standardisation, Clinical Data Management, Statistical Programming, and Data Standards.

Take Solutions is a supply chain partner of choice for large manufacturers and distributors in the high-tech, pharma/medical, industrial products/services, and consumer packaged goods industries who need to help maximize their investment in Oracle, but minimize the cost and risk of customizations.

 

Take Solutions Share Price

48.91 0.95 (1.98%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2581.65
Infosys 1318.60
HCL Tech. 1442.50
Wipro 204.35
Tech Mahindra 1511.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×